Does LYPRESSIN Cause Off label use? 50 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 50 reports of Off label use have been filed in association with LYPRESSIN. This represents 78.1% of all adverse event reports for LYPRESSIN.
50
Reports of Off label use with LYPRESSIN
78.1%
of all LYPRESSIN reports
50
Deaths
43
Hospitalizations
How Dangerous Is Off label use From LYPRESSIN?
Of the 50 reports, 50 (100.0%) resulted in death, 43 (86.0%) required hospitalization, and 33 (66.0%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LYPRESSIN. However, 50 reports have been filed with the FAERS database.
What Other Side Effects Does LYPRESSIN Cause?
Abdominal distension (51)
Vomiting (51)
Abdominal pain (50)
Appendicitis (50)
Ascites (50)
Condition aggravated (50)
Hyponatraemia (50)
Sepsis (50)
Somnolence (50)
Appendicolith (49)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)